Font Size: A+AA-
EN
CN
Online Message
Contact Information
One of telephone, mobile phone number, e-mail is required
Contact
Tel
Mobile phone
Email
QQ
WeChat Account
Message
Other additions
Verification code
  • 2.jpg
    Medical InsurancePass GQCEVBP Bid Winner

    Aoding®

    Pitavastatin Calcium Tablets

    1、Commonly recommended by international authoritative guides
    2、Strong lipid-lowering effect, significantly lowering the risk of cardiovascular and cerebrovascular events
    3、A safer statin lipid-lowering dru
    Not metabolized by CYP3A4, few drug interactions
    Less than 2% metabolized by the kidneys, with little effect on kidney function
    No increased risk of new onset diabetes, more suitable for patients with diabetes and prediabetes

Product Explain

  • 【Generic Drug Consistency Evaluation】Pass GQCE
  • 【Medical Insurance】National Medical Insurance Class B
  • 【Drug Name】
    Generic Name:Pitavastatin Calcium Tablets
    Trade Name:Aoding®
    English Name:Pitavastatin Calcium Tablets
    Chinese Pinyin:Pifatatinggai Pian
  • 【Indications】Treatment of hypercholesterolemia, familial hypercholesterolemia
  • 【Usage and Dosage】
    Generally, pitavastatin calcium 1 to 2 mg is given orally once daily for adults.
    The dose may be increased or decreased as appropriate for age and treatment response, and may be increased in cases of inadequate LDL-cholesterol reduction to a maximum daily dose of 4 mg.
    Precautions:
    1. For patients with liver disease, the initial dose is 1 mg daily and the maximum dose is 2 mg daily. (Refer to [Caution in administration] [pharmacokinetics])
    2. Because of the possibility of adverse events associated with rhabdomyolysis as the dose (blood concentration) of this preparation increases, pay sufficient attention to the pre-myocardial symptoms of rhabdomyolysis such as elevated CK (CPK), myoglobinuria, muscle pain and weakness when increasing the dose to 4 mg.. [Dosing above 8 mg in foreign clinical trials is terminated due to rhabdomyolysis or related adverse events].
    3. For patients with moderate and severe renal insufficiency (glomerular filtration rate 30-59 ml/min/1.73 m2 and 15-29 ml/min/1.7 3m2 without hemodialysis, respectively) and end-stage renal disease on hemodialysis, the initial dose of 1 mg once daily and the maximum dose of 2 mg once daily should be administered.
  • 【Packaging Specification】 Aluminum-plastic packaging, 7 tablets/box, 24/box.
  • 【Shelf Life】24 months
  • 【Approval Number】H20203268
  • 【Manufacturer】Nanjing Chang Ao Pharmaceutical Co., Limited
See the manual for other details

Contact Cooperation

Contact Address:5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Postal code:518003
Contact:Miss Ma
Tel:0755-25527386
In addition to contacting the manufacturer by phone, you can also post an agent message for that vendor to contact you by messaging.
I want to be an agent
Species of interest
Message
Others
Agency Area
Other regions
Contact Information
One of telephone, mobile phone number, e-mail is required
Contact
Tel
Mobile phone
Email
QQ
WeChat Account
Verification code
Northwest China
Southwest China
South China
Central China
East China
Northeast China
North China
Top
  • Service Tel0755-2552 7000
  • Business Tel0755-2552 7386